In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer.

MLA

Mäkimattila, S., et al. “In Vivo Glucose-Stimulated Amylin Secretion Is Increased in Nondiabetic Patients with Pancreatic Cancer.” Metabolism: Clinical and Experimental, vol. 50, no. 9, Sept. 2001, pp. 1036–42. EBSCOhost, https://doi.org/10.1053/meta.2001.25801.

APA

Mäkimattila, S., Hietaniemi, K., Kiviluoto, T., Timonen, T., & Yki-Järvinen, H. (2001). In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer. Metabolism: Clinical and Experimental, 50(9), 1036–1042. https://doi.org/10.1053/meta.2001.25801

Chicago

Mäkimattila, S, K Hietaniemi, T Kiviluoto, T Timonen, and H Yki-Järvinen. 2001. “In Vivo Glucose-Stimulated Amylin Secretion Is Increased in Nondiabetic Patients with Pancreatic Cancer.” Metabolism: Clinical and Experimental 50 (9): 1036–42. doi:10.1053/meta.2001.25801.